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ABSTRACT (Maximum 200 Words)
Our previous studies showed that both glucosylceramide synthase (GCS) and Pglycoprotein (P-gp) are overexpressed in Adriamycin-resistant human breast cancer cells, MCF-7-AdrR cells. When these cells were transfected with GCS antisense (asGCS), a stable 30% decrease in GCS activity was obtained. Experiments with paclitaxel (Taxol) showed that intracellular levels of drug were 8.6-fold greater in the asGCStransfected cell line, MCF-7-AdrR/asGCS, compared to MCF-7-AdrR cells. In assessing Pgp, we observed a dramatic decrease in the level of MDRl expression (80%) by RT-PCR that translated into a similar decrease in P-gp protein levels. To confirm the influence of GCS on MDR1 expression, we inhibited GCS. Treatment of MCF-7-AdrR cells with GCS inhibitor, l-phenyl-2-palmitoylamino-3-morpholino-l-propanol (PPMP), or with GCS siRNA, produced a significant decrease in MDR1 mRNA levels compared to untreated. These results were used in manuscript for publication, which showed that P-gp expression can be downregulated by either GCS antisense transfection or chemical inhibition of GCS. In order to determine whether overexpression of GCS is a general characteristic of chemotherapy resistance, we assessed GCS expression and glycolipid levels in Adriamycin-, cisplatin-, etoposide-, and paclitaxel-resistant breast cancer cells. 
INTRODUCTION
Poor response to chemotherapy is a major clinical problem, and in most instances drug resistance is underlying cause (1). This is a most undesirable situation, and patients and oncologists would welcome its possible correction. In breast cancer nearly 50% of patients demonstrate primary and/or secondary resistance to Adriamycin (2) . Several mechanisms of drug resistance are being examined, and avenues to reverse resistance are being sought. Research strategies in this area have become increasingly aimed at molecular targets such as P-glycoprotein (P-gp), multidrug resistance associated protein (MRP), topoisomerase, and Bcl-2 protooncogene, to name a few. Overexpression of the membrane efflux transporter, P-gp is one of the most consistent biological alterations in drug resistance (1, 3) . P-gp (170 kDa) is the product of the mdrl gene, an energy-dependent pump that reduces the intracellular concentration of specific anticancer drugs, and it has been studied extensively. Our approach to drug resistance is new and involves ceramide metabolism. The area has been reviewed (4, 5) . Several front-line anticancer agents elicit the formation of ceramide, a proapoptotic lipid messenger (6, 7) , by activating either the de novo or sphingomyelinase pathways of ceramide production (4, 7) .
Drugs that induce cellular ceramide generation include anthracyclines (Adriamycin), Vinca alkaloids, etoposide (VP-16), paclitaxel, and fenretinide (4-HPR). If ceramide formation in response to drug treatment is blocked, then the cytotoxic impact of the drug is largely reduced (8, 9) . This demonstrates ceramide's role in drug responses. Ceramide added directly to cells circumvents the enzyme route of ceramide formation and promotes an apoptotic cascade directly (9, 10) . Our group showed that increased cellular capacity for ceramide glycosylation, catalyzed by glucosylceramide synthase (GCS), is associated with chemotherapy resistance in cancer cells (11) (12) (13) (14) (15) . In cultured breast cancer cells, sensitivity to anthracyclines and taxanes can be decreased or increased simply by manipulation of GCS activity (13, 16, 17) . For example, transfection of drugsensitive MCF-7 breast cancer cells with GCS cDNA confers resistance to Adriamycin (16) , and tranfection of multidrugresistant MCF-7-AdrR breast cancer cells with antisense GCS (asGCS) increases cell sensitivity to chemotherapy by a factor of 28-fold for Adriamycin, more than 100-fold for vinblastine, and more than 200-fold for paclitaxel (13 We used a slightly different approach than we planned when we wrote the project, namely, we incorporated the use of another cell line, MCF-7-AdrR/asGCS. This cell line is an Adriamycin-resistant breast cancer cell line stably transfected with GCS antisense. In this cell line, GCS activity is knocked down by 30%. This tool helped us to understand the implications of GCS in the mechanisms of drug resistance in breast cancer cells, in particular as regards P-gp. This research allowed us to make important discoveries on the connection between GCS and P-gp, and this work has been reported in a publication (18). Moreover, this work can be related to task three of the statement of work: "Determine whether overexpression of GCS and overexpression of P-gp are allied or dissociated". Real-time RT-PCR showed that MDR1 expression in MCF-7-AdrR cells treated with D-L-threo-PPMP and D-L-erythro-PPMP was reduced by 58% and 12%, respectively, compared with untreated MCF-7-AdrR cells.
5.
Influence of GCS siRNA on MDR1 gene expression in MCF-7-AdrR cells.
To reinforce the results obtained with PPMP and to confirm that changes in MCF-7-AdrR/asGCS cellular MDR1 expression were not due to clonal artifacts, we used GCS siRNA to treat MCF-7-AdrR cells. siRNA was introduced into cells using lipofectAMINE in serum-free medium for 4 hours. After 48 hours, both GCS and MDR1 mRNA were dramatically decreased by GCS siRNA compared with lipofectAMINE only controls. The siRNA had no effect on expression levels of c-actin. agents by acting as a drug efllux pump (1, 2). P-glycoprotein exports enzyme in glycolipid biosynthesis, contributes to cancer cell many types of chemotherapy drugs, including Vinca alkaloids, resistance to chemotherapy. We previously showed that anthracyclines, paclitaxel, actinomycin D, and epipodophyllotoxins. transfection of doxorublicn-resistant MCF-7-AdrR cells with Like P-glycoprotein, MRP is a transport protein (3); however, the GCS antisense restored cell sensitivity to doxorubicin and transport of unconjugated chemotherapeutic agents by MRP greatly enhanced sensitivity to vinblastine and paclitaxel. In seems to require glutathione. MDR in tumors can also be caused that study, doxorublcin promoted generation of ceramide in by overexpression of proteins such as antiapoptotic proteins MCF-7-AdrR/GCS antisense cells; the present study Implicates belonging to the Bcl-2 family (4,5) and by loss of tumor suppressor factors in addition to ceramide that augment sensitivity to protein p53 (6, 7). Others factors responsible for chemotherapy chemotherapy. Although GCS antisense cells showed enhanced resistance include reduction of topolsomerase It activity (8). ceramide formation compared with MCF-7-AdrR when chalmodification of glutathione $-transferase activity (9), and uplenged with paclitaxel, GCS antisense cells also showed a 10-regulation of rafts and caveolae, which are glycosphingolipidfold increase in levels of Intracellular drug (paclitaxel and enriched constituents of microdomains (10). vinblastine). In addition, transfected cells had dramatically Glucosylceramede synthase (GCS) catalyzes the first glycosyladecreased expression (80176) of P-glycoproten and a 4-fold tion step in the biosynthesis of glycosphingolipids (11, 12 ). This decrease in the level of cellular gangliosides. Chemical central enzyme of ceramide metabolism has also been implicated inhibition of GCS produced the same effects as antisense in MDR (13) . Glycosphingoliplds, including glucosylceramide, transfectlon: exposure ofMCF-7-AdrR cells to the GCS Inhibitor lactosyiceramide, and gangliosides, play an essential role in cell 1-phenyl-2-palmitoylamino-3-morphollno-I-propanol (PPMp, development, cell death, tumor progression, and pathogen/host 5.0 1nol/L, 4 days) decreased gangloside levels, restored interaction (13, 14) . In addition, membrane gangliosides can sensitivity to vinblastine, enhanced vinblastine uptake 3-fold, decrease the sensitivity of human melanoma cells to ionizing and diminished expression of MDR1 by 58%, compared with radiation (15) . In that study, radioresistant melanoma cells were untreated controls. A similar effect was shown In vinblastinmade radiosensitive by exposure to either fumonisin B 1 , which resistant KB-VO.O1 cells; after 7 days with PPMP (10 pmol/L), blocks ganglioside biosynthesis at the juncture of ceramide MDR1 expression fell by 84% and P-glycoprotein protein levels synthase, or Vibrio chelerse neuraminidase, which cleaves cell decreased by 50%. MCF-7-AdrR cells treated with small surface gangliosides. Conversely, adding bovine brain GM1 to Interfering RNAs to specifically block GCS also showed a radiosensitive melanoma cells conferred radloresistance (15) . dramatic decrease in MDRI expression. This work shows that Targeting glycolipid metabolism has proven useful in altering limiting GCS activity down-regulates the expression of MIDR1, a chemotherapy responses in numerous human tumor cell lines phenomenon that may drive the chemosensitization associated (13, (16) (17) (18) .
with blocking ceramide metabolism. The data suggest that In previous studies, we increased the level of MDR by lipids play a role In the expression of multidrug resistance, transfecting doxorubicin-resistant human breast cancer cells (Cancer Res 2005 n 65(9): 3861-7) (MCP-7-AdrR) with GCS. and we enhanced cellular sensitivity to anthracyclines, Vinca alkaloids, and taxanes by transfecting MCF-7-AdrR cells with GCS antisense (16, 19) . Although doxorubicin Introduction treatment of GCS antisense transfectants increased intracellular Development of resistance to chemotherapeutic agents is a levels of ceramide (16), which is a second messenger of apoptosis, major concern in cancer patients. Resistance to chemotherapy the extremely high sensitivity of MCF-7-AdrR/GCS antisense cells is associated with myriad mechanisms that decrease drug to Y'nca alkaloids and taxanes suggested the participation of cytotoxicity. Two members of the large family of ABC transmechanisms other than ceramide signaling in cellular responses. porters confer multidrug resistance (MDR) in human cancer
We have observed equivalent Intracellular levels of rhodamlne-123 cells: P-glycoprotein and multidrug resistance protein (MVI).
in MCF-7-AdrR/GCS antisense cells and in rhodamine-123-P-glycoprotein, a membrane-resident glycoprotein encoded by the exposed MCF-7 parental cells, which indicates that GCS antisense transfection reverts drug retention in MCF-7-AdrR cells on a par with the drug-sensitive phenotype (16, 19 . 100 units/mL penicillin, 100 pIg/mL streptomytotal volume of 50 pL, was done for 35 cycles in a thormocycler cln, and 584 mg/L L-glutamine. Cells were cultured in a humidified, 5% CO.
(Eppendorf Scientific, Westbury, NY); each cycle comprised denaturation atmosphere tissue culture incubator and subeultured weeldy using trypsinat 94°C for 30 seconds, annealing at 55*C for 30 seconds, and elongation EDTA (0.05%, 0.53 mmol/L) solution, MCF-7-AdrR cells transfected with at 72°C for I minute. IRT-PCR products were analyzed by 1% agarose gal GCS antisense (MCF-7-AdrR/GCS antisense) were cultured in RPMI 1640 electrophoresls stained with ethidiunm bromide. P-Acdn primer (Stratacontaining the above components and G418 (400 jig/mL; ref 16) .
gene, Cedar Creek, TX) was used as a housekeeping gene. The KB-VO.01 multidrug-resistent human epidermold carcinoma cell line Real-time PCR. A real-time quantitative PCR analysis was done using (21) was grown in high glucose (4.5 g/L) DMEMwIth 10% fetalbovineserum the Rotor-Gene 3000 (Corbett Research. Sydney. Australia). Primers and and vinblastlne (10 ng/mL). Cells were a gift from Dr. Michael Gottesman probe sequences for MDR1 were chosen as follows. MDRI forward 5'-(National Cancer Institute, Bethesda, MD).
GGTTTATAGTAGGATTTACACGTGGTTG-3, MDR1 reverse 5?-AAGATAGCytotoxicity assays. Assays were done as described previously (13) .
TATCTTTGCCCAGACAGC-39. and MDR1 probe 5' PAM CTAACCCTTGTBriefly, cells were seeded in 96-well plates (5,000 cells per well) in 0.1 mI. GATTTTGGCCATCAGTCC Tamra 3'. Human D-actin was used as ,PMI 1640 containing 10% PBS and cultured at 37°C for 24 hours before endogenous control. Both assays used the SuperScript III Platinium oneaddition of vinblastine sulfate or paclitaxel (Taxol), both of which were step quantitative RT-PCR system (nvtrogen, Chicago, QL). obtained from Sigma (St Louis, MO). Drugs were added in PBS-free Glucosylearamlde synthase gene silencing by email interfering RNA. medium (0.1 mL), and cells were grown at 37'C for the Indicated periods.
The small Interfering (sINA) sequence targeting human GCS was selected Drug cytotoxicity was determined by the CellTiter 96 AQueous One using the BLOCK-IT RNAi Designer program: reagents were synthesized by Solution cell proliferation assay (Promega, Madison, WI). Absorbance at Invitrogen (Carlsbad, CA). The sIRNA duplex with the following sense and 490 nm was measured by a fluorescent reader (Microplate FL600, Bio-Tek.
entisense sequences was used: 5'-CCAGGAUAUGAAGUUGCAA (sense) and Winoosld, VT).
6-UUGCAACUUCAUAUCCUGG (antisense). Established protocols were Analysis of lipids. Analysis was done as described previously (13, 22) . followed (24. 25). Briefly, sINA was introduced into cells using LipofectBriefly, for ceramide, sphingamyelin, phospholipid. and neutral lipid AMINE 2000 in serum-free medium for 4 hours. FBS was added, and after analysis, cells were seeded 6-well plates (60,000 cells per well) in 10% FBS 48 hours, total RNA was extracted and used to examine GCS and MDRI BRPMI 1640. After 24 hours, medium was replaced with 5% PBS medium mniNA levels. LipofectAMINE 2000 alone and expression of P-aedn were containing [ 3 HJpaImitic acid (1.0 CICl/mL culture medium; DuPont/NEN, used as controls. Boston, MA) for 24 hours. Total lipids were extracted as described (22), and Purification and analysis of gangflosides. Cells harvested in PBS were the resulting organic lower phase was withdrawn and evaporated under a homogenized in 6 mL chloroform/methanol (1:1, v/v); the mixture remained strearm of nitrogen. Lipids were resuspended In 0.1 mL chloroform/ overnight at room temperature. After centrifugation, the supematant was methanol (21-, vlv), and resolution was by TLC using solvent systems dried and the lipid residue was taken up In chloroform/methanol (1:1) and described (23). Commercial lipid standards (Avanti Polar Lipids, Alabaster, centrifuged to remove all solid particles. Addition of PBS in a volume ratio AL) were cochromategraphed. After development, lipids were visualized by of 1:1.0.7 (chloroform/methanol/PBS) separated the organic phase from the iodine vapor staining. and the area of Interest was scraped into 0.5 iLo ganglloslde-contamning aqueous phase, as previously described (26). After water. EcoLume scintillation fluid (4.5 mL; ICN, Costa Mesa, CA) was added, thorough vortex mixing, the tube was centrifuged, and the upper phase samples were mixed, and radioactivity was quantitated by liquid containing gangliosides was withdrawn. Partitioning was repeated twice, scintillation spectrometry. For ceremide quantitatlon, cells were grown in each time by adding methanol/PBS (10.7. v/v) to the lower phase, followed 15-cm dishes, and total lipids were extracted and analyzed by TLC using a by centrifugation. The upper phases were pooled, and gangliosides solvent system containing chloroform/acetic acid (90.10. v/v). Approxiwere recovered from the aqueous solution by column chromatography on mately 880 pg of lipid were loaded per lane. After development, TLC plates C18-bonded silica gel. Ganglioside profiles were determined by highwere sprayed with cone. sulfuric acid, and heated In an oven (30 minutes, performance TLC on Silica Gel 60 plates (Merck, Darmstadt, Germany) 180°3). The ceramide chars were quantitated by scanning densitometrn developed in chloroform/methanol/0.2% aqueous calcium chloride using a ceramide standard curve (1.0-6.0 jig). Silica Gel G prescored (55:45:10, v/v/v) and sprayed with resorcinol-HCI reagent Ganglloslde slalic TIC plates were purchased from Analtech (Newark, DL) Before the acid content was determined by the periodate-resorcinol method (27). above procedure, plates were acid washed by running in methenol/HCI [ 3 U]Paclitaxel and [ 5 il~vinblastine uptake studies. Cells were seeded (90:10, v/v), and thoroughly dried before use. into 12-well plates at 100,000 cells per well in L0 mL of complete medium.
Western blot for P-glyeoprotein. Confluent monolayers of MCF-7-AdrR
After 24 hours at 37°C, the medium was removed; cells were rinsed with and MCF-7-AdrR/GCS antisense cells were rinsed, harvested in PBS, and PBS and incubated for 10 to 90 minutes with 0.5 ml of 5% PBS RPMI 1640 lysed in a PBS buffer containing 10% glycerol, 1% Triton X-100, 1.0 mmol/L containing 500 nmol/L paclitaxel plus 0.25 pCi [SMpaclitaxel (Moravek Na3VO4, 10 mmol/L P-glycerophosphate, 50 mmol/L NaF, 0.1 mmol/L Biochemical, Bras, CA), or 500 nmol/L vinbiastine plus 0.25 pICi phenylmethylsulfonyl fluoride, 2 pg/mL leupeptin, and 10 pg/mL aprotinin rH]vinblastine (Moravek biochemical). After removal of culture medium, for 30 minutes on ice. The mixture was centrifuged at 11,000 X g for 15 cells were washed twice with 5% PBS RPMI 1640 and lysed with 0.2 mL of minutes at 4*C. Equal allquots of protein (25 jig) were resolved using 4% to 596 FBS RPMI 1640 containing 0.02% SDS. Intracellular radioactivity was 20% gradient SDS-PAGE (Invitrogen, Chicago, IL). The transferred measured by liquid scintillation counting.
Modulation of P-Glyaoprotein by Glycolipids
MDlL Induction by glycolipids. KB-VO.OI cells were seeded into 6.0-cm drug efflux is the most widely characterized drug resistance dishes in complete medium. After 24 hours, medium was removed and cells mechanism in cancer cells (28), and it is highly expressed in were Incubated In 5% PBS DMEM medium containing either 30 ltg/mL CS MCF-7-AdrR cells (13) . We previously reported that levels P-D-glucosylceranlde (Avant! Polar Lipids, Alabaster, AL), 0.5 Opm/L of rhodamLne-123, a substrate of P-glycoprotein, were -5-doxorubicin(LKTLaboratories, StPauN,MN)aspositive control, or 10 g/mL fold higher in MCF-7-AdrR/GCS antisense compared with palmitic acid (Sigma) as negative control. Cells were treated for 48 MCF-7-AdrR cells (19). This suggests that GCS ntisense transfecand RNA was analyzed by real-time RT-PCIM Chemical Inhibition of gbueosyleeramide synthase. DL-Threo-1-tion alters drug uptake and/or retention. Experiments with phenyl-2-palhitoylamlno-3-morpholtno-l-propanol (PPMP) was from Biochemotherapy drugs showed that after 60 minutes, intracellular mol Research Laboratories (Plymouth Meeting PA) and DL-erythro-PPMP levels of vInblastine were 12-fold greater in MCF-7-AdrR/GCS and D-threo-PPMP were from Matreya (Pleasant Gap, PA). These reagents antisense compared with MCF-7-AdrR cells (Fig. 2) . Similarly, were used as described in the figure legends.
uptake of paclitaxel Increased 8.6-fold in GCS antisense transStatistical analyses. Student's t test was used for statistical analysis.
fectants compared with MCF-7-AdrR cells (Fig. 2) . Because of the pronounced differences in drug levels In the two Results cell lines, we assessed P-glycoprotein expression, by mENA and Previously, we showed that GCS antisense transfeetion of protein.
As shown in Fig. 3 . the level of MDR1 mRNA, evaluated multidrug-resistant MCF-7-AdrR cells enhanced cell sensitivity to by reverse transcription-PCR (RT-PCR), was dramatically lower doxorubicin, vinblastine, and paclltaxel (19) . A doxorubicinIn MCF-7-AdrR/GCS antisense compared with MCP-7-AdrR cells. induced increase in ceramide levels and caspase activity Is in
We confirmed this by Western blot; whereas MCF-7-AdrR cells keeping with ceramide-medlated cytotoxic responses to chemocontained characteristically elevated levels of P-glycoprotein, therapy (16) , but it is not clear whether ceramide is the only factor MCF-7-AdrRIGCS antisense cells were nearly devoid of Pinvolved in the significantly (>100-fold) increased sensitivity of GCS glycoprotein. These data suggest that high drug levels attainable antisense-transfected cells to 'lnc alkaloids and paclitaxel.
In MCF-7-AdrR/GCS antisense cells are a consequence of the Initial studies on ceramide production measured with 1 3 H]paldramatic decrease (-80%) in P-glycoprotein expression. Thus, ndtate showed that similar levels of trildated ceramide were the stable 30% decrease in GCS activity of MCF-7-AdrR/GCS formed In both MCF-7-AdrR and MCF-7-AdrR/GCS antisense antisense cells (16) seems to have an important influence on cells in response to vinblastine and paclitaxel challenge (Fig. 1A) .
intracellular drug levels and on P-glycoprotein expression. For this Using mass analysis, however, we found that cerarnide producreason, we investigated whether partial inhibition of GCS would tion in response to paclltaxel (1.0 gmol/L) was enhanced 3-fold cause other alterations, in particular, in membrane lipid in MCF-7-AdrR/GCS antisense cells compared with parental composition. MCF-7-AdrR cells after 24 hours of treatment (Fig. iB) . To further Steady-state t There were no significant differences in cholesterol esters or other inhibition of GCS by chemical means reversed resistance of glycerophospholipids between transfected and parent cells.
MCF-7-AdrR cells to vinblastine. To examine the generality of this Because GCS is pivotal In the genesis of cerebrosides and response, we used KB-VO.01 cells, a head/neck multidrug-resistant gangliosides, we also looked for changes in glycosphingolipid epidermoid carcinoma call line that expresses both GCS and MDR1 content Although MCF-7-AdrR and MCF-7-AdrR/GCS antisense (33). As shown in Fig, SA , MDR1 expression in KB-VO.01 cells was cells expressed a similar ganglioside pattern (GM3, GMZ, GD3, lowered 70% by D-threo-PPMP (10 pmnol/L) and 38% by xr,L-threoand GDla; data not shown). sialic acid assay showed that the PPMIP (15 pinol/L). Therefore, the n-threo isomer is the most level of gangliosides was 4-fold lower in GCS antisense trensfected effective inh)lbitor of GCS compared with the racemic mixture. KBcells (data not shown).
VO.01 cell treatment with o-threo-PPMP for a prolonged period To determine whether depletion of gangliosides and reduced (7 days) induced a dramatic decrease (84%) in MDRI mRNA levels expression of P-glycoprotein were strictly a consequence of GCS (ig. 5B). Moreover, P-glycoprotein protein levels in these cells down-regulation by antisense transfection, we evaluated the diminished by 50%, compared with the untreated control (Fig. 5C) . influence of DL-threo-PPMP, a chemical inhibitor of GCS (29-31),
We next investigated the effect of glycolipid supplementation on on ganglioside synthesis and P-glycoprotein expression in MCF-MDRI expression. Growth of KB-VO.01 cells with cell-permeable 7-AdrR cells. A 4-day exposure to nL-threo-PPMP produced a C8-glucosylceramide (30 gg/mL) elicited a 2-fold increase in MDRI 34% decrease in ganglioside levels in MCF-7-AdrR Cells (Fig. 44) .
mRNA levels (Fig. 6 ) a response nearly comparable to the influence Moreover, PPMP greatly diminished the expression of MDR1 in of Adrlamycin (0.5 Ftmol/L) on MDRI expression (Fig. 6) . Palnitic MCF-7-AdrR cells, with shown stereospecificity (Fig. 4B) . Unlike acid, used as a lipid control, had no influence on MDRl expression. %,L-threo-PPMP, nL-erythro-PPMP Is not a GCS inhibitor (32), and this stereolsomer had no influence on MDRI expression.
Real-time RT-PCR showed that MDR1 expression in MCF-7-AdrR cells treated with D,L-thrao-PPMP and D.L-erytro-PPMP was reduced by 58% and 12%, respectively, compared with untreated MCP-7-AdrR cells (Fig. 4B) . To reinforce the results obtained d", with PPMP and to confirm that changes in MCF-7-AdrR/GCS S antisense cellular MDRl expression were not due to clonal artifacts, we used GCS sERNA to treat MCF-7-AdrR cels. AsPgP shown in Fig. 4C , after 48 hours, both GCS and MDR1 mRNA were dramatically decreased by GCS siMNA compared with LipofectAMlNE only controls. The siRNA had no effect on ji-acn f. In addition to their role as a structural component of the plasma (35-37). These organized domains have been suggested to membrane, gangliosides might regulate signaling events. In participate in cellular processes, such as signal transduction, melanoma cells, transient ganglioside depletion by GCS inhibition membrane trafficking, and protein sorting (38) . Expression of the reduced tumorigenic capacity (43). Gangliosides can also induce principal component of caveolae, caveolin-1, in MCF-7-AdrR and production of nitric oxide, tumor necrosis factor-cr, and cyclo-MCF-7-AdrR/GCS antisense cells, determined by Western blot, was oxygenase 2 and activate extracellular signal-regulated kinase and not affected by antisense down-regulation of GCS (data not c-ftm /stress-activated protein kinase Idnase, p38, and nuclear shown), although it should be mentioned that this assay is not a factor KB (NF-KB; rd 44). Our work showed that inhibiting the good estimate of the status of cellular lipids in rafts/caveolae. activity of GCS severely limited the expression of MDR1 and its However, we found that tmnsfected cells had lower levels of product, P-glycoprotein. Studies have shown that the MDR1 gangliosides, the slalic acid-containing glycosphingolipids. Ganpromoter can be activated directly by anticancer agents such gliosides have been shown to influence lipid order and hydration as vincristine, daunorubicin, doxorubicin, and colchicine (45); *was not evident in MCF-7-AdrR/GCS antisense cells challenged with either vinblastine or paclitaxcl (Fig. IA) ; however, lipid mass analysis by TLC char clearly showed elevated ceramide levels in X
•.drug-challenged GCS antisense transfectants (Fig. IB) In conclusion, our work shows that limiting GCS activity by either GCS antisense transfection, siRNA transfection, or PPMP KB-VO.01 D-threo-PPMP treatment down-regulates the expression of P-glycoprotein. It should be noted, however, that drug resistance through enforced overexpression of GCS in wild-type MCF-7 cells, using a retroviral Figure 6 . Influence of PPMP on MDRI mRNA and protein (P-glycoprotein) tetracycline-on expression system, did not rely on P-glycoprotein levels In KB-V0. Therefore, ceramide-signaled death cascades and depletion of were extracted and used for real-time RT-PCR (B) and Western blot analysis cellular P-glycoprotein are likely contributory to heightened (C). Seven-day exposure to o-threo PPMP, which necessitated a medium chemosensitivity in MCF-7-AdrR/GCS antisense. We propose that change, Increased cell doubling time by twice, compared with controls. Points, mean from two Independent experiments; bars, ±SD. *, P < 0.05; -, P < 0.01. overexpression of GCS contributes to chemotherapy resistance by however, an association between glycollpids and the MDR1 promoter has not been clearly established. Some studies have -*
suggested that glycolipids. in particular gangliosides, modulate 8 multidrug resistance. For example, the up-regulation of GM3 biosynthesis In fenretinide-adapted A2780 ovarian cancer cells 2. has been correlated with fenretinide resistance (46). In human leukemia cells, ganglioside depletion is believed to account for PDMP-mediated reversal of multidrug resistance, and GM3 Overexpression of glucosyleeramide synthase (GCS), a pivotal enzyme in glycolipid biosynthesis, contributes to cancer cell resistance to chemotherapy.
We previously demonstrated that transfection of doxorubicin-resistant MCF-7-AdrR cells with GCS antisense (asGCS) restored cell sensitivity to doxorubicin and greatly enhanced sensitivity to vinblastine and paclitaxel. In that study, doxorubicin pronioted generation of ceramide in I4CP-7-AdrR/asGCS cells; the present study implicates factors other than ceramide in the sensitivity of asGCS-transfected cells to chemotherapy. Although asGCS cells demonstrated enhanced ceramide formation compared to MCF-7-AdrR when challenged with paclitaxel, asGCS cells also demonstrated a 10-fold increase in levels of intracellular drug (paclitaxel, vinblastine). In addition, transfected cells had dramatically decreased (80%) expression of P-glycoprotein (P-gp), and a 4-fold decrease in the level of cellular gangliosides. Chemical inhibition of GCS produced the same effects as antisense transfection: exposure of MCF-7-AdrR cells to the GCS inhibitor PPMP (1-phenyl-2-palmitoylamino-3-morpholino-lpropanol) (5.0 pM; 4 days) decreased ganglioside levels, restored sensitivity to vinblastine, enhanced vinblastine uptake 3-fold, and diminished expression of MDR1 by 58%, compared to untreated controls. A similar effect was demonstrated in vinblastine-resistant KB-VO.01 cells; after 7 days with PPMP (10 pM), MDR1 expression fell by 84% and P-gp protein levels decreased by 50%. MCF-7-AdrR cells treated with small interfering RNAs to specifically block GCS also showed a dramatic decrease in MDRl expression. This is the first evidence that limiting GCS activity downregulates the expression of MDRI, a mechanism that may drive the chemosensitization associated with targeting ceramide metabolism. The data suggest that lipids play a role in multidrug resistance, and that limiting ganglioside biosynthesis could be a promising approach for reversing multidrug resistance in cancer.
